Lupin Limited (BOM:500257)
India · Delayed Price · Currency is INR 2,277.00
+3.50 (0.15%)
At close: Jun 16, 2026
Lupin Market Cap
Lupin has a market cap or net worth of 1.04 trillion as of June 16, 2026. Its market cap has increased by 15.74% in one year.
Market Cap
1.04T
Enterprise Value
1.02T
Revenue
279.58B
Ranking
n/a
PE Ratio
19.56
Stock Price
2,277.00
Market Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 1.04T, an increase of 104,202.24%. That is a compound annual growth rate of 29.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 1.04T | 7.91% |
| Dec 31, 2025 | 964.76B | -10.05% |
| Dec 31, 2024 | 1.07T | 78.05% |
| Dec 29, 2023 | 602.42B | 80.75% |
| Dec 30, 2022 | 333.29B | -22.86% |
| Dec 31, 2021 | 432.05B | -2.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.55T |
| Dr. Reddy's Laboratories | 1.06T |
| Abbott India | 558.26B |
| GlaxoSmithKline Pharmaceuticals | 359.26B |
| J. B. Chemicals & Pharmaceuticals | 355.66B |
| Rubicon Research | 221.49B |
| AstraZeneca Pharma India | 210.63B |
| Granules India | 185.61B |